Dublin, Feb. 09, 2018 -- The "Thermo Fisher Ion 520 DNA Sequencing Chip: Comparison and Cost Analysis" report has been added to ResearchAndMarkets.com's offering.
Today a main challenge in life science research is to reduce the price of genomic analysis, and the time taken to do it. Back in 2003, the cost of sequencing the human genome was almost $3B. That decreased to $10,000 in 2011, and is headed towards $1,000 in the next few years.
Thermo Fisher, with 8% of the microfluidic product market, is one of the companies most involved in sequencing applications, along with its rival Illumina. However, the two companies have different objectives.
Thermo Fisher intends to reduce analysis time with fast throughput and short single-end reads. Illumina has high throughput with short paired reads. To deliver fast reading, Thermo Fisher uses Ion Torrent technology, which relies on technology similar to an image sensor.
Key Topics Covered:
1. Overview/Introduction
2. Company Profile and Supply Chain
Physical Analysis
Physical Analysis Methodology
Package Analysis
View and Dimensions
Opening
Cross-section: PCB Substrate, Flow Cell Member
Die Analysis
Die View and Dimensions: Flow Chamber, Pixels
Die Active Area View and Delayering
Die Process
Die Cross-Section: Metal Layers, Wells, ISFET
Manufacturing Process Flow
Wafer Fabrication Unit
Packaging Process Flow
3. Cost Analysis
Overview of the Cost Analysis
Supply Chain Description
Yield Hypotheses
Wafer Cost Analyses:
Front-end Cost
Die Cost
Packaging Cost Analysis
Packaging Back-End Cost
Packaging Cost by Process Step
Component Cost
4. Estimated Price Analysis
For more information about this report visit https://www.researchandmarkets.com/research/hxhjnm/thermo_fisher_ion?w=12
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Genomics


SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Instagram Outage Disrupts Thousands of U.S. Users
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Washington Post Publisher Will Lewis Steps Down After Layoffs
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 



